Synthesis and primary evaluation of the hepatoprotective properties of novel pyrimidine derivatives

A. B. Vyshtakalyuk; V. E. Semenov; V. V. Zobov; I. V. Galyametdinova; L. F. Gumarova; A. A. Parfenov; N. G. Nazarov; O. A. Lenina; S. A. Kondrashova; Sh. K. Latypov; G. V. Cherepnev; M. S. Shashyn; V. S. Reznic

doi:10.1134/S106816201704015X

Synthesis and primary evaluation of the hepatoprotective properties of novel pyrimidine derivatives

作者: Vyshtakalyuk A.B.¹, Semenov V.E.¹, Zobov V.V.¹^,2, Galyametdinova I.V.¹, Gumarova L.F.¹, Parfenov A.A.¹, Nazarov N.G.¹^,2, Lenina O.A.¹, Kondrashova S.A.¹, Latypov S.K.¹, Cherepnev G.V.¹^,2, Shashyn M.S.¹, Reznic V.S.¹
隶属关系:
1. Arbuzov Institute of Organic and Physical Chemistry, Kazan Research Center
2. Kazan (Volga region) Federal University
期: 卷 43, 编号 5 (2017)
页面: 604-611
栏目: Article
URL: https://journals.rcsi.science/1068-1620/article/view/228701
DOI: https://doi.org/10.1134/S106816201704015X
ID: 228701

如何引用文章

全文:

开放存取

##reader.subscriptionAccessGranted##
受限制的访问

订阅存取

详细
作者简介
参考
补充文件
统计

详细

Based on the active ingredient of the drug Ximedon (1,2-dihydro-4,6-dimethyl-1-N-(2-hydroxyethyl)pyrimidone-2, referred below to as pyrimidine (I), novel derivatives containing biogenic acids: succinic, L-ascorbic, para-aminobenzoic, nicotinic, and L-2-amino-4-(methylthio)butanoic (L-methionine) acids have been synthesized. The parameters of acute toxicity (LD₅₀) have been studied. The antitoxic effect of the compounds upon the injury by the hepatotropic poison carbon tetrachloride has been examined as the primary evaluation of their hepatoprotective properties. It has been found that, according to toxicological safety, the compounds synthesized belong to classes III and IV (moderately and little toxic compounds). The conjugates of pyrimidine (I) with ascorbic acid and methionine (LD₅₀ more than 5400 mg/kg) are least toxic. Pyrimidine (I) and its derivatives possess the antitoxic activity upon acute poisoning with carbon tetrachloride; the combined injection of carbon tetrachloride with pyrimidine (I) or its derivatives leads to an increase in the survival of animals and the normalization of the integral functional parameters, weight and body temperature, which decrease upon toxic injury. In addition, pyrimidine (I) and some of its derivatives (conjugates with L-ascorbic, succinic, para-aminobenzoic, and nicotinic acids) decrease the weight coefficients of the liver and kidneys (the organ-to-body-weight ratio) and the activity of transaminases, the markers of hepatic cytolysis, which increase upon toxic injury with carbon tetrachloride. The area of the pathological injury of the liver by steatosis and necrosis decreases by the action of pyrimidine (I) and its novel derivatives (conjugates with L-ascorbic, succinic, and nicotinic acids) two to three times. Advantages of pyrimidine (I) and its novel derivatives over the hepatoprotective drug Thiotriazolin have been revealed.

关键词

pyrimidines, Ximedon, hepatoprotectors, liver diseases, toxic hepatitis

补充文件

附件文件

动作

1. JATS XML

下载

用户名
密码
记住我

忘记您的密码?	注册

用户名
密码
记住我

忘记您的密码?	注册

Synthesis and primary evaluation of the hepatoprotective properties of novel pyrimidine derivatives

全文:

详细

关键词

作者简介

A. Vyshtakalyuk

V. Semenov

V. Zobov

I. Galyametdinova

L. Gumarova

A. Parfenov

N. Nazarov

O. Lenina

S. Kondrashova

Sh. Latypov

G. Cherepnev

M. Shashyn

V. Reznic

补充文件